Photograph of Mena Gaballah, PharmD Download V-card

Mena Gaballah, PharmD

Associate

mgaballah@crowell.com
Phone: +1 202.624.2875
1001 Pennsylvania Avenue NW
Washington, DC 20004-2595

Mena Gaballah is an associate in Crowell & Moring’s Washington, D.C. office. He is a member of the firm’s Intellectual Property Practice Group, where he provides full-service intellectual property counseling services to clients, with an emphasis in pharmaceutical, chemistry, biotechnology, and materials science technologies. Mena’s practice also focuses on matters involving healthcare litigation, healthcare recovery, and FDA regulatory and compliance. He works alongside pharmaceutical and medical device manufacturers, healthcare insurers, and other life sciences companies.

Mena received his J.D. from the University of Maryland School of Law in 2018. During his time in law school, Mena was a student attorney in the University of Maryland School of Law Intellectual Property and Entrepreneurship Clinic where he conducted patent and trademark clearance searches, filed trademark applications, and helped counsel on business formation issues. Mena was also a summer intern at the Food and Drug Administration where he served as liaison with key legislative staff preparing resource material for Congressional hearings. Mena graduated with a certificate in Healthcare from the nationally recognized Healthcare Law Program and wrote his graduation paper on the opioid epidemic. He was also a member of the Moot Court Board.

While attending law school, he was also enrolled at the University of Maryland School of Pharmacy. He graduated with a Doctor of Pharmacy in 2018. During pharmacy school, Mena’s experiential education sites included the University of Maryland R Adams Cowley Shock Trauma Center Multi-Trauma Intensive Care Unit, Union Memorial Hospital Cardiac Intensive Care Unit, Springfield Psychiatric Hospital, the Veterans Affairs Hospital in Baltimore, MD, and several independent and chain retail pharmacies. Mena is a published author in the Journal of Managed Care Pharmacy, as well as in Pharmacy Times and the Baltimore Sun.

Mena is registered to practice before the United States Patent and Trademark Office, a licensed pharmacist in the state of New Jersey, and is a member of the District of Columbia Bar. He graduated in 2012 from Monmouth University in New Jersey with a Bachelor’s of Science degree in Biology with a concentration in Molecular Cell Physiology.

Education

  • Monmouth University, B.S. biology, with concentration in molecular cell physiology (2012) cum laude
  • University of Maryland School of Law, J.D. (2018) cum laude
  • University of Maryland School of Pharmacy, PharmD (2018)

Affiliations

Admitted to practice: District of Columbia, U.S. Patent and Trademark Office (USPTO)

View More

"Faulty Jury Instruction Wipes Out $740 Million Verdict," Crowell & Moring’s Trade Secrets Trends (June 10, 2020). Authors: Mena Gaballah, PharmD and Joshua M. Rychlinski.
Publication
"HHS Advisory Opinion Clarifies PREP Act Preemption Measures and Protection for Pharmacists," Mass Tort, Product, and Consumer Litigation Alert (May 27, 2020). Contacts: John Fuson, Chalana N. Damron, Mena Gaballah, PharmD, Mariam Sarwar
Client Alert / Newsletter
"The Regulatory Pathway To A Vaccine For COVID-19," Law360 (May 22, 2020). Authors: John Fuson, Anne Elise Herold Li, and Mena Gaballah, PharmD.
Publication
"FDA Reissues EUA for Non-NIOSH Approved Respirators Manufactured in China," Mass Tort, Product, and Consumer Litigation Alert (May 8, 2020). Contacts: John Fuson, Chalana N. Damron, Mena Gaballah, PharmD, Mariam Sarwar, John Arszulowicz
Client Alert / Newsletter
"FDA Tightens the Rules for Antibody (Serology) Test Manufacturers," Mass Tort, Product, and Consumer Litigation Alert (May 5, 2020). Contacts: John Fuson, Mena Gaballah, PharmD
Client Alert / Newsletter
"FDA Turns to 503A Compounding Facilities to Mitigate COVID-19 Drug Shortages," Mass Tort, Product, and Consumer Litigation Alert (May 1, 2020). Contacts: John Fuson, Anne Elise Herold Li, Chalana N. Damron, Mena Gaballah, PharmD, Mariam Sarwar
Client Alert / Newsletter
"FDA Issues Final Guidance Aimed at Alleviating COVID-19 Drug Shortages through Outsourcing Facilities," Mass Tort, Product, and Consumer Litigation Alert (April 21, 2020). Contacts: John Fuson, Anne Elise Herold Li, Chalana N. Damron, Mena Gaballah, PharmD, Mariam Sarwar
Client Alert / Newsletter
"FDA Final Guidance for PPE Shortages at Sterile Compounding Pharmacies not Registered as Outsourcing Facilities," Mass Tort, Product, and Consumer Litigation Alert (April 14, 2020). Contacts: John Fuson, Chalana N. Damron, Mena Gaballah, PharmD
Client Alert / Newsletter
"Emergency Use Authorization for Ventilators and Related Equipment," Mass Tort, Product, and Consumer Litigation Alert (April 7, 2020). Contacts: John Fuson, Chalana N. Damron, Mena Gaballah, PharmD, Mariam Sarwar
Client Alert / Newsletter
"The FDA Reverses Course and Authorizes the Importation of Non-NIOSH Approved Respirators Manufactured in China," Mass Tort, Product, and Consumer Litigation Alert (April 6, 2020). Contacts: John Fuson, Chalana N. Damron, Mena Gaballah, PharmD, Mariam Sarwar
Client Alert / Newsletter

For all Highlights, News & Knowledge, please click here to view desktop bio.

Crowell & Moring LLP is an international law firm with more than 500 lawyers representing clients in litigation and arbitration, regulatory, and transactional matters. The firm is internationally recognized for its representation of Fortune 500 companies in high-stakes litigation, as well as its ongoing commitment to pro bono service and diversity. The firm has offices in Washington, DC, New York, Los Angeles, San Francisco, Orange County, London, and Brussels.

View Desktop Site | Mobile Sitemap

Contact | Subscribe | Terms of Use | Privacy Statement | Alumni

© Crowell & Moring LLP 2020
Attorney advertising - prior results do not guarantee a similar outcome.